Should there be more molecular staging of head and neck cancer to improve the choice of treatments and thereby improve survival?
about
Prognostic significance of interleukin-8 and CD163-positive cell-infiltration in tumor tissues in patients with oral squamous cell carcinoma.HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker?Sheddase activity of tumor necrosis factor-alpha converting enzyme is increased and prognostically valuable in head and neck cancer.Prognostic impact of preoperative serum interleukin-6 levels in patients with early-stage oral squamous cell carcinoma, defined by sentinel node biopsy.IFN-γ and other serum cytokines in head and neck squamous cell carcinomas.
P2860
Should there be more molecular staging of head and neck cancer to improve the choice of treatments and thereby improve survival?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Should there be more molecular ...... and thereby improve survival?
@en
Should there be more molecular ...... and thereby improve survival?
@nl
type
label
Should there be more molecular ...... and thereby improve survival?
@en
Should there be more molecular ...... and thereby improve survival?
@nl
prefLabel
Should there be more molecular ...... and thereby improve survival?
@en
Should there be more molecular ...... and thereby improve survival?
@nl
P1476
Should there be more molecular ...... and thereby improve survival?
@en
P2093
Gaetano Paludetti
P304
P356
10.1097/MOO.0B013E3282F6A4B0
P577
2008-04-01T00:00:00Z